• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ-熊去氧胆酸抑制非酒精性脂肪性肝炎:FXR/SHP/LXRα/FASN 信号消除脂肪变性依赖性过氧化损伤。

Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling.

机构信息

Department of Gastroenterology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.

Endoscopy Center, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China.

出版信息

Nutrients. 2023 Mar 2;15(5):1255. doi: 10.3390/nu15051255.

DOI:10.3390/nu15051255
PMID:36904254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10005659/
Abstract

Nonalcoholic steatohepatitis (NASH) reflects the outcome of steatosis-based peroxidative impairment. Here, the effect and mechanism of γ-muricholic acid (γ-MCA) on NASH were investigated on the basis of its actions in hepatic steatosis, lipid peroxidation, peroxidative injury, hepatocyte apoptosis, and its NAFLD activity score (NAS). The agonist action of γ-MCA on farnesoid X receptor (FXR) upregulated the small heterodimer partner (SHP) expression of hepatocytes. An increase in SHP attenuated the triglyceride-dominated hepatic steatosis which was induced in vivo by a high-fat high-cholesterol (HFHC) diet and in vitro by free fatty acids depending on the inhibition of liver X receptor α (LXRα) and fatty acid synthase (FASN). In contrast, FXR knockdown abrogated the γ-MCA-dependent lipogenic inactivation. When compared to their excessive production in HFHC diet-induced rodent NASH, products of lipid peroxidation (MDA and 4-HNE) exhibited significant reductions upon γ-MCA treatment. Moreover, the decreased levels of serum alanine aminotransferases and aspartate aminotransferases demonstrated an improvement in the peroxidative injury of hepatocytes. By TUNEL assay, injurious amelioration protected the γ-MCA-treated mice against hepatic apoptosis. The abolishment of apoptosis prevented lobular inflammation, which downregulated the incidence of NASH by lowering NAS. Collectively, γ-MCA inhibits steatosis-induced peroxidative injury to ameliorate NASH by targeting FXR/SHP/LXRα/FASN signaling.

摘要

非酒精性脂肪性肝炎(NASH)反映了基于脂肪变性的过氧化损伤的结果。本研究基于 γ-熊去氧胆酸(γ-MCA)在肝脂肪变性、脂质过氧化、过氧化损伤、肝细胞凋亡和其非酒精性脂肪性肝病活动评分(NAS)中的作用,研究了其在 NASH 中的作用和机制。γ-MCA 对法尼醇 X 受体(FXR)的激动作用上调了肝细胞的小异二聚体伴侣(SHP)表达。SHP 的增加减弱了高脂肪高胆固醇(HFHC)饮食体内诱导和游离脂肪酸体外诱导的以甘油三酯为主的肝脂肪变性,这取决于肝 X 受体 α(LXRα)和脂肪酸合酶(FASN)的抑制。相比之下,FXR 敲低消除了 γ-MCA 依赖性的生脂失活。与 HFHC 饮食诱导的啮齿动物 NASH 中过度产生的情况相比,脂质过氧化产物(MDA 和 4-HNE)在 γ-MCA 处理后显著减少。此外,血清丙氨酸氨基转移酶和天冬氨酸氨基转移酶水平的降低表明肝细胞过氧化损伤得到改善。通过 TUNEL 测定,损伤的改善保护了 γ-MCA 处理的小鼠免受肝凋亡。凋亡的消除阻止了小叶炎症,从而通过降低 NAS 降低 NASH 的发生率。综上所述,γ-MCA 通过靶向 FXR/SHP/LXRα/FASN 信号抑制脂肪变性诱导的过氧化损伤来改善 NASH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/9771fd9949ad/nutrients-15-01255-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/868d741757c6/nutrients-15-01255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/ff36666096f1/nutrients-15-01255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/a5fadc39c4d6/nutrients-15-01255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/955c81b407f3/nutrients-15-01255-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/48baec13d336/nutrients-15-01255-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/cf7e8a1242b0/nutrients-15-01255-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/9771fd9949ad/nutrients-15-01255-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/868d741757c6/nutrients-15-01255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/ff36666096f1/nutrients-15-01255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/a5fadc39c4d6/nutrients-15-01255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/955c81b407f3/nutrients-15-01255-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/48baec13d336/nutrients-15-01255-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/cf7e8a1242b0/nutrients-15-01255-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf83/10005659/9771fd9949ad/nutrients-15-01255-g007.jpg

相似文献

1
Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling.γ-熊去氧胆酸抑制非酒精性脂肪性肝炎:FXR/SHP/LXRα/FASN 信号消除脂肪变性依赖性过氧化损伤。
Nutrients. 2023 Mar 2;15(5):1255. doi: 10.3390/nu15051255.
2
Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.肝小异二聚体伴侣的破坏可诱导实验性非酒精性脂肪性肝炎中脂肪变性和炎症的分离。
J Biol Chem. 2020 Jan 24;295(4):994-1008. doi: 10.1074/jbc.RA119.010233. Epub 2019 Dec 12.
3
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.胆汁酸会促使小鼠发生非酒精性脂肪性肝炎。
JHEP Rep. 2021 Oct 13;4(1):100387. doi: 10.1016/j.jhepr.2021.100387. eCollection 2022 Jan.
4
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway.薯蓣皂苷元通过肝 FXR-SHP-SREBP1C/PPARα/CD36 通路减轻非酒精性肝脂肪变性。
Eur J Pharmacol. 2023 Aug 5;952:175808. doi: 10.1016/j.ejphar.2023.175808. Epub 2023 May 30.
5
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.游离脂肪酸抑制小异二聚体伴侣(SHP)的激活,脂联素可拮抗胆汁酸诱导的非酒精性脂肪性肝炎超肥胖患者的肝损伤。
Hepatology. 2013 Apr;57(4):1394-406. doi: 10.1002/hep.26225.
6
Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis farnesoid X receptor activation.绞股蓝皂苷通过激活法尼酯X受体改善高脂饮食诱导的非酒精性脂肪性肝炎。
Front Nutr. 2022 Aug 24;9:914079. doi: 10.3389/fnut.2022.914079. eCollection 2022.
7
Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.肝细胞核受体 SHP 抑制非酒精性脂肪性肝炎小鼠模型中的炎症和纤维化。
J Biol Chem. 2018 Jun 1;293(22):8656-8671. doi: 10.1074/jbc.RA117.001653. Epub 2018 Apr 17.
8
Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.Nrf2 通过与 FXR 竞争乙酰化酶结合来抑制 LXRα 依赖性肝内脂质生成。
Antioxid Redox Signal. 2011 Oct 15;15(8):2135-46. doi: 10.1089/ars.2010.3834. Epub 2011 Jun 13.
9
MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.微小RNA-122通过阴阳1抑制脂滴形成和肝脏甘油三酯蓄积。
Cell Physiol Biochem. 2017;44(4):1651-1664. doi: 10.1159/000485765. Epub 2017 Dec 6.
10
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.

引用本文的文献

1
Ultrasound-driven ROS-scavenging nanobubbles for synergistic NASH treatment via FXR activation.超声驱动的活性氧清除纳米气泡通过激活法尼醇X受体协同治疗非酒精性脂肪性肝炎。
Ultrason Sonochem. 2025 Jul;118:107352. doi: 10.1016/j.ultsonch.2025.107352. Epub 2025 Apr 26.
2
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.健康与疾病中的胆汁酸代谢及信号传导:分子机制与治疗靶点
Signal Transduct Target Ther. 2024 Apr 26;9(1):97. doi: 10.1038/s41392-024-01811-6.
3
Obesogenic polystyrene microplastic exposures disrupt the gut-liver-adipose axis.

本文引用的文献

1
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
2
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
3
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.肠道微生物群与人类非酒精性脂肪性肝病:从代谢紊乱中解析微生物特征。
肥胖相关的聚苯乙烯微塑料暴露会破坏肠道-肝脏-脂肪轴。
Toxicol Sci. 2024 Mar 26;198(2):210-220. doi: 10.1093/toxsci/kfae013.
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):279-297. doi: 10.1038/s41575-020-0269-9. Epub 2020 Mar 9.
4
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.奥贝胆酸治疗非酒精性脂肪性肝炎:多中心、随机、安慰剂对照 3 期临床试验的中期分析。
Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.
5
Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease.脂毒性肝细胞衍生的外泌体 microRNA-192-5p 通过 Rictor/Akt/Forkhead Box 转录因子 O1 信号通路激活非酒精性脂肪性肝病中的巨噬细胞。
Hepatology. 2020 Aug;72(2):454-469. doi: 10.1002/hep.31050. Epub 2020 May 16.
6
The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide.长链酰基辅酶 A 脱氢酶这种脂肪酸氧化酶可以成为线粒体过氧化氢的一个来源。
Redox Biol. 2019 Sep;26:101253. doi: 10.1016/j.redox.2019.101253. Epub 2019 Jun 15.
7
Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways.双重特异性磷酸酶 12 通过抑制脂肪生成和凋亡信号调节激酶 1 通路调节肝脏脂质代谢。
Hepatology. 2019 Oct;70(4):1099-1118. doi: 10.1002/hep.30597. Epub 2019 Apr 22.
8
Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.血清胆汁酸模式与双胞胎中非酒精性脂肪性肝病(NAFLD)的存在相关,并且在经活检证实的非酒精性脂肪性肝病患者中,随着纤维化阶段的增加,呈现出剂量依赖性变化。
Aliment Pharmacol Ther. 2019 Jan;49(2):183-193. doi: 10.1111/apt.15035. Epub 2018 Dec 2.
9
The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β Activation.线粒体凋亡效应蛋白 BAX/BAK 激活半胱天冬酶-3 和 -7 以触发 NLRP3 炎性体和 caspase-8 驱动的 IL-1β 激活。
Cell Rep. 2018 Nov 27;25(9):2339-2353.e4. doi: 10.1016/j.celrep.2018.10.103.
10
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.肠法尼醇 X 受体激动剂和肠道微生物群激活 G 蛋白胆汁酸受体-1 信号通路以改善代谢。
Hepatology. 2018 Oct;68(4):1574-1588. doi: 10.1002/hep.29857. Epub 2018 May 21.